These observations align with our experimental data, which indicate that PR immunoreactivity in glioma tissues and cell lines, potentially reflecting receptor expression in tumor-associated endothelial or stromal cells rather than exclusively in transformed glial cells. The gene discussed is PGR; the disease is central nervous system cancer.